MedPath

NOVO-RESERPINE TAB 0.25MG

NOVO-RESERPINE TAB 0.25MG

Discontinued
DIN Number

00021784

Drug Class

Human

Market Date

Dec 31, 1967

Company
HC

novopharm limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00021784
AIG Number0104657001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C02AA02 RESERPINE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification24:08.32
Health Canada Classification

ACTIVE INGREDIENTS (1)

RESERPINEActive
Strength: .25 MG
Monograph: RESERPINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.